Chief Executive Officer Dudum Andrew covered exercise/tax liability with 90,672 shares, sold $13,813,792 worth of shares (240,771 units at $57.37) and exercised 289,703 shares at a strike of $1.05, increasing direct ownership by 6% to 95,105 units (SEC Form 4)

6/17/25 8:07:04 PM ET

$HIMS

Medical/Nursing Services

Health Care

Get the next $HIMS alert in real time by email

SEC FORM 4 SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dudum Andrew

(Last)

(First)

(Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO

94123

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
06/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	06/13/2025		M		164,368	A	⁽¹⁾	253,679	D
Class A Common Stock	06/13/2025		F		90,672	D	$55.48	163,007	D
Class A Common Stock	06/16/2025		S⁽²⁾		2,792	D	$56.3526⁽³⁾	160,215	D
Class A Common Stock	06/16/2025		S⁽²⁾		40,120	D	$56.4414⁽⁴⁾	245,074	I	Held by Trustee of Dudum Family Community Property Trust
Class A Common Stock	06/16/2025		S⁽²⁾		7,414	D	$56.9019⁽⁵⁾	237,660	I	Held by Trustee of Dudum Family Community Property Trust
Class A Common Stock	06/16/2025		M⁽²⁾		108,334	A	$2.43	268,549	D
Class A Common Stock	06/16/2025		M⁽²⁾		17,001	A	$2.43	285,550	D
Class A Common Stock	06/16/2025		S⁽²⁾		17,001	D	$58.6086⁽⁶⁾	268,549	D
Class A Common Stock	06/16/2025		S⁽²⁾		90,624	D	$56.389⁽⁷⁾	177,925	D
Class A Common Stock	06/16/2025		S⁽²⁾		17,710	D	$56.9177⁽⁸⁾	160,215	D
Class A Common Stock	06/17/2025		S⁽²⁾		15,945	D	$58.5033⁽⁹⁾	144,270	D
Class A Common Stock	06/17/2025		S⁽²⁾		49,165	D	$59.4469⁽¹⁰⁾	95,105	D
Class A Common Stock								1,194,545	I	Held by Trustee of AD 2022 GRAT 3 dated 11-28-2022
Class A Common Stock								1,286,627	I	Held by Trustee of AD 2021 GRAT dated 11-1-2021
Class A Common Stock								534,491	I	Held by Trustee of AD 2022 GRAT
Class A Common Stock								1,584,506	I	Held by Trustee of AD 2023 GRAT dated 9-5-2023
Class A Common Stock								829,185	I	Held by Trustee of AD 2022 GRAT 2 dated 9/7/2022
Class A Common Stock								2,874,769	I	Held by Trustee of Dudum Family Heritage Trust UAD 8-10-2021
Class A Common Stock								990,410⁽¹¹⁾	I	Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015
Class A Common Stock								186,723⁽¹²⁾	I	Held by Trustee of AD 2025 GRAT 3 dated 5-27-2025

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Unit	⁽¹⁾	06/13/2025		M			35,242	⁽¹³⁾	⁽¹³⁾	Class A Common Stock	35,242	$0	105,726	D
Restricted Stock Unit	⁽¹⁾	06/13/2025		M			35,446	⁽¹⁴⁾	⁽¹⁴⁾	Class A Common Stock	35,446	$0	248,126	D
Restricted Stock Unit	⁽¹⁾	06/13/2025		M			74,530	⁽¹⁵⁾	⁽¹⁵⁾	Class A Common Stock	74,530	$0	819,828	D
Restricted Stock Unit	⁽¹⁾	06/13/2025		M			19,150	⁽¹⁶⁾	⁽¹⁶⁾	Class A Common Stock	19,150	$0	287,256	D
Stock Option (right to buy)	$2.43	06/16/2025		M⁽²⁾			108,334	⁽¹⁷⁾	06/16/2030	Class A Common Stock	108,334	$0	864,731	D
Stock Option (right to buy)	$2.43	06/16/2025		M⁽²⁾			17,001	⁽¹⁸⁾	06/16/2030	Class A Common Stock	17,001	$0	85,009	D

Explanation of Responses:

1. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

2. The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

3. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $56.20 - $56.495. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

4. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $55.83 - $56.815. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

5. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $56.82 - $57.05. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

6. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $55.79 - $56.68. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

7. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $55.79 - $56.78. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

8. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $56.79 - $57.26. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

9. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $58.22 - $58.945. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

10. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $59.01 - $59.75. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

11. The balance represents an in-kind transfer of 186,723 Class A Common Shares to the AD 2025 GRAT dated 5-27-2025.

12. The balance represents an in-kind transfer of 186,723 Class A Common Shares from the Andrew Dudum 2015 Trust dated July 2, 2015.

13. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022.

14. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023.

15. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024.

16. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2025.

17. The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020.

18. Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.

Remarks:

	/s/ Alexandra Cotter Wilkins, Attorney-in-Fact	06/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Get the next $HIMS alert in real time by email

Date	Price Target	Rating	Analyst
6/4/2025	$61.00 → $65.00	Buy	Needham
4/29/2025	$30.00	Buy → Hold	TD Cowen
2/18/2025	$42.00 → $60.00	Overweight → Equal-Weight	Morgan Stanley
1/10/2025	$24.00 → $25.00	Neutral → Sell	Citigroup
1/7/2025	$35.00	Buy	BTIG Research
12/17/2024	$42.00	Overweight	Morgan Stanley
11/14/2024		Buy → Underperform	BofA Securities
8/22/2024	$24.00	Buy	Needham

Chief Executive Officer Dudum Andrew covered exercise/tax liability with 90,672 shares, sold $13,813,792 worth of shares (240,771 units at $57.37) and exercised 289,703 shares at a strike of $1.05, increasing direct ownership by 6% to 95,105 units (SEC Form 4)

Chat with this insight

Recent Analyst Ratings for
$HIMS

$HIMS
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Chief Commercial Officer Chi Michael converted options into 87,106 shares, covered exercise/tax liability with 48,166 shares and sold $1,021,844 worth of shares (17,102 units at $59.75), increasing direct ownership by 9% to 278,654 units (SEC Form 4)